roflumilast topical foam 0.3%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for roflumilast topical foam 0.3%, covering 2025-12-23 to 2025-12-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa [Phase 2]